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ABSTRACT
Knowledge of all binding sites for transcriptional
activators and repressors is essential for compu-
tationally aided identification of transcriptional
networks. The techniques developed for defining
the binding sites of transcription factors tend to be
cumbersome and not adaptable to high throughput.
We refined a versatile yeast strategy to rapidly and
efficiently identify genomic targets of DNA-binding
proteins. Yeast expressing a transcription factor is
mated to yeast containing a library of genomic frag-
ments cloned upstream of the reporter gene URA3.
DNA fragments with target-binding sites are identi-
fied by growth of yeast clones in media lacking
uracil. The experimental approach was validated
with the tumor suppressor protein p53 and the
forkhead protein FoxI1 using genomic libraries for
zebrafish and mouse generated by shotgun cloning
of short genomic fragments. Computational analy-
sis of the genomic fragments recapitulated the
published consensus-binding site for each protein.
Identified fragments were mapped to identify the
genomic context of each binding site. Our yeast
screening strategy, combined with bioinformatics
approaches, will allow both detailed and high-
throughput characterization of transcription factors,
scalable to the analysis of all putative DNA-binding
proteins.
INTRODUCTION
Identiﬁcation of DNA-binding sites for transcription
factors can be a diﬃcult task, in particular because they
often consist of short, degenerate DNA sequences. Tradi-
tionally, DNA-binding sites have been identiﬁed by elec-
trophoretic mobility shift assays (EMSA) (1), SELEX
enrichment (2,3) and DNAse I footprinting assays (4).
More recently, microarray technology has been adapted
to this task (5), but the identiﬁed in vitro binding sites do
not necessarily address the in vivo activity of a particular
binding site. The human genome encodes 2000–3000
transcription factors (6–9), but at present only 123 trans-
cription factors (from any species) have experimentally
determined binding sites in the JASPAR database
(http://mordor.cgb.ki.se/cgi-bin/jaspar2005/jaspar_db.pl).
This indicates a strong need for additional approaches
that are more eﬃcient.
Experimental strategies in the yeast Saccharomyces
cerevisiae can be fast, cheap and almost universally
accessible, as has been demonstrated by the broad use
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tional experimental strategies in yeast for high-throughput
screens (11–18). More recently, Deplancke and colleagues
(19) studied 72 digestive tract promoters of Caenorhabditis
elegans in high-throughput yeast assays with 117 proteins
and found a large number of previously unknown
protein–DNA interaction networks. Recent techniques
involving high-throughput sequencing called ChIP-Seq
(20), provides a promising new approach, but requires
high-quality antibodies to the transcription factor of
interest and suﬃcient starting material for chromatin
immunoprecipitation. Thus the technique is not readily
scalable to hundreds or thousands of transcription factors.
We have created the necessary tools and protocols
to perform yeast screens that identify both the sequences
of DNA-binding targets of transcription factors and
biologically active sites of binding. This article demon-
strates the utility using libraries made from the zebraﬁsh
and mouse genomes. We have validated the approach for
both libraries using two transcription factors: Foxl1 and
p53. For both transcription factors, yeast screens generate
accurate consensus DNA-binding sites and potential
target genes. The techniques are readily scalable to new,
high-throughput sequencing approaches for comprehen-
sive binding data on large numbers of transcription
factors.
METHODS
Transcription factor expression plasmid
A cDNA expression vector, pYoh-1, was constructed by
inserting a double-stranded oligo containing multiple
restriction enzyme sites (forward, 50-TCG AGC TCA
GTC GAC TGG TAC CGA TAT CGA ATT CGG ATC
CCC GGG GCC TC-30 and reverse, 50-CAT GGA GGC
CCC GGG GAT CCG AAT TCG ATA TCG GTA CCA
TGC GAC TGA GC-30) into pACT2 (Clontech) at NcoI/
XhoI sites and replacing LEU2 with ADE2 (Supplemen-
tary Data). The ADE2 gene was ampliﬁed from yeast
genomic DNA using the primers 50-AAT GCA ATC GAT
TAA CGC CGT ATC GTG ATT AAC-30 and 50-ACG
TAA GCG GCC GCC GCT ATC CTC GGT TCT
GC-30. Zebraﬁsh FoxI1 cDNA coding region was sub-
cloned into pYoh-1 at the multiple cloning site and fused
with the Gal4 activation domain and the HA epitope
tag [originally described in Ref. (21)]. Yeast expression
plasmids for human p53 have been described previously
(22,23).
Transcription factor plasmids were introduced into
MAT  yeast strains W303 (kindly provided by Carl
Wu’s laboratory; genotype ade2-1, can1-100, his3-11,15,
leu2-3,112, trp1-1, ura3-1) or BY4735 (ade2D::hisG
his3D200 leu2D0 met15D0 trp1D63 ura3D0) (24). Standard
yeast manipulations were performed as described (25).
Fusion protein expression of FoxI1 was conﬁrmed by
western blot using anti-HA tag antibody.
Yeastgenomic libraries
To generate the genomic libraries, the URA3 reporter
plasmid pHQ366 (26) was modiﬁed by replacing the
PstI-p53-binding site-EcoRI linker with a new PstI-
EcoRI linker (50-GTA TCT CGA GG-30 and 50-AAT
TCC TCG AGA TAC TGC A-30), yielding plasmid
pYoh366. Zebraﬁsh or mouse genomic DNA was partially
Tsp509I-digested, gel-puriﬁed and cloned into pYoh366 at
the EcoRI site. Ligation reactions were ethanol precipi-
tated and electroporated into Escherichia coli ElectroMAX
DH5a-E cells (Invitrogen). The library complexity was
assessed by counting a serial dilution of transformants
on LB-ampicillin plates. The remainder was plated on
large LB-ampicillin plates, allowed to grow and washed
into a ﬂask containing LB media. Plasmids were isolated
using standard procedures. Yeast strain BY404 (MATa
ade2D::hisG his3D200 leu2D0 trp1D63 ura3D0) (24) was
transformed with genomic fragment-containing pYoh366
and frozen in aliquots (5 10
8 cells/ml).
Yeast mating
We used the method from Ref. (27) as an optimized mating
protocol, originally designed for yeast two-hybrid screen-
ing. Mating of two haploid yeast strains of opposite mating
type, each harboring one of the respective plasmids,
results in the formation of doubly transformed diploid
zygotes. An aliquot of BY404 with the genomic library in
pYoh366 was combined with a freshly raised culture of
p53-expressing or FoxI1-expressing yeast (MATa) and
then subjected to the standard mating procedures. Mating
eﬃciency was calculated by the number of diploid colonies
on plates selecting for diploid yeast per total colony
number on YPAD or YPD plates. When ADE2 plasmids
were used (i.e. the FoxI1 screening), yeast expressing the
transcription factor also contained an empty HIS3
plasmid. This allowed for selection of diploid yeast on the
actual screening plates (-his, -trp, -ura) while using the
ADE2-based color assay for detection of the transcription
factor plasmid.
Sequencing of positive clones
Library plasmids were rescued from positive yeast clones
as described (28) and sequenced using Forward366
(50-GCG CTT TAA GAG AAA ATA TTT GTC
CTG-30) and Reverse366 (50-CGG CTA TTT CTC AAT
ATA CTC CTA ATT AAT AC-30). Alternatively, the
genomic library fragments were PCR ampliﬁed directly
from yeast using Forward366 and ReverseUra (50-GTA
GCA GCA CGT TCC TTA TAT GTA GC-30).
ReverseUra targets the plasmid in a region outside the
SPO13 promoter. Before sequencing, 20ml of PCR
product were treated with 0.3U shrimp alkaline phospha-
tase (Amersham) and 3U EXO I (USB) in 20mM Tris–
HCl, pH 8.0 and 10mM MgCl2 for 1h at 378C and 808C
for 15min. The fragments were diluted with 95mlo f
ddH2O and sequenced with nested primer Reverse366.
RESULTS
General strategy inyeast for genome-wide screening
forbinding sites ofDNA-binding proteins
We devised an improved assay system to perform whole
genome screens for transcription factor-binding sites.
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quickly eliminate false-positives (Figure 1). In essence,
a transcription factor is tested against random genomic
fragments to isolate DNA that can be directly bound by
the protein of interest. By fusing the transcription factor
to the activating domain of the yeast transcription factor
GAL4 (GAL4AD), the protein will become a transcrip-
tional activator, regardless of the normal role it plays
in vivo or any co-factors that it would normally need to
activate transcription. Binding of the transcription factor
to the genomic DNA fragment results in activation of the
URA3 reporter gene and growth of yeast on plates lacking
uracil.
The screening eﬃciency relies on several key aspects:
(i) high-quality libraries of genomic DNA with potentially
several-fold coverage of the zebraﬁsh and mouse genomes;
(ii) tight repression of the SPO13 promoter upstream of
the URA3 reporter gene; (iii) negative selection of genomic
library yeast in 5-FOA containing media prior to screens
resulting in few false-positives; (iv) ADE2-based expres-
sion plasmids for both auxotrophic selection and a visual
color ‘sectoring’ assay; (v) maintenance of libraries and
transcription factors in haploid yeast of opposite mating
type for fast and easy execution of library screens and
(vi) PCR ampliﬁcation of the genomic fragments directly
from yeast for rapid sequencing and reanalysis of the
positive genomic fragments.
Construction ofwhole genome libraries for zebrafish
andmouse
Libraries were constructed in plasmid pYoh366 that
contains the URA3 reporter gene downstream of the
SPO13 promoter (28) in a CEN plasmid (one copy per
yeast cell) with the selective marker gene TRP1 (Figure 1)
(29). Genomic DNA from zebraﬁsh and mouse was
partially digested with Tsp509I. Genomic fragments of
 500bp in length were gel-puriﬁed and cloned into the
EcoRI site of pYoh366. A total of 3 10
7 independent
clones with an average size of 300bp were obtained for the
zebraﬁsh library, an approximate 4- to 6-fold coverage of
the zebraﬁsh genome. A total of 1.7 10
7 independent
clones with an average size of 700bp were obtained for the
mouse library, representing an approximately 3- to 4-fold
coverage of the mouse genome. For both libraries, >90%
of plasmids had inserts. The libraries were transformed
into yeast strain BY404 (MATa) (24), and >10
8 indepen-
dent colonies from each library were pooled and frozen
in aliquots.
Yeastexpression plasmids for DNA-binding proteins
Several marker genes (such as HIS3 or LEU2) are avail-
able for yeast expression plasmids. These markers allow
for screens that involve more than one transcription
factor. The marker gene ADE2 is particularly advanta-
geous because loss of the plasmid can be monitored by
accumulation of a red adenine precursor on plates with
limiting amounts of adenine (30). A colony that grows on
plates lacking uracil yet shows red sectors or is completely
red indicates that part or all of the colony has lost the
transcription factor plasmid, easily identifying it as a false-
positive clone.
Whole-genome screens forDNA-binding proteins in yeast
Screens were performed according to the outline in
Figure 2. A total of 2 10
8 haploid yeast of mating type
MATa containing the genomic library were mated on
non-selective YPD plates with an equal number of haploid
yeast (MATa) containing the expression plasmid for
a transcription factor. This approach is signiﬁcantly
more eﬃcient than transforming the library into yeast
Figure 1. (A) Strategy of genomic library screens in yeast to identify
binding sites for transcription factors. The transcription factor of
interest is expressed in haploid yeast of mating type MATa. A library
of genomic fragments cloned upstream of URA3 in the reporter
plasmid is maintained in MATa yeast. Yeast mating combines the two
plasmids resulting in URA3 activation and growth on SC-Ura plates
if the transcription factor binds to the genomic DNA fragment.
(B) Details of the cloning site for genomic fragments. The SPO13
promoter represses basal transcription and the Tsp509I fragments are
cloned into an engineered EcoRI site. Primers for ampliﬁcation of the
genomic fragments directly from the yeast colonies are indicated with
half arrows. By placing one primer in the URA3 gene and the other in
the SPO13 promoter, it prevents ampliﬁcation of the endogenous
sequences.
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(i) maintaining the library in yeast makes it an easily
renewable resource and (ii) mating assays are more
convenient and eﬃcient than DNA transformation. The
typical mating eﬃciency was 5–10%, yielding >10
7 diploid
yeast per screen. After 3 days of growth at 308C, Ura
+
clones (non-sectoring white colonies in the case of ADE2
plasmids) were single-colony puriﬁed and checked for
plasmid-dependency of the Ura
+ phenotype. The library
plasmids were rescued, transformed into BY404, retested
for the Ura
+ phenotype in mating assays for the trans-
cription factor, sequenced and analyzed computationally.
CharacterizationofthemousegenomicDNAlibraryusingp53
p53 is a tumor suppressor protein that is activated
in response to cellular stresses. It has well-established
DNA-binding characteristics (2,31). All experiments were
performed with the complete mouse library of 1.7 10
7
independent genomic fragments. Growing the yeast
containing the genomic library in 5-FOA-containing
media prior to the screen eliminated background from




We performed a screen with p53 under fully optimized
conditions. Yeast with an empty control plasmid was
processed in parallel to determine the background of false-
positives. We obtained 330 Ura
+ colonies per 1 10
6
diploid yeast for p53, whereas yeast with an empty
plasmid yielded only two colonies per 1 10
6.
The very low level of false-positives in our assay allowed
us to streamline the screening procedure signiﬁcantly.
Once Ura
+ clones emerged after 2–5 days, a PCR reaction
was used to amplify the genomic insert directly from yeast.
One primer hybridized to the upstream SPO13 sequence
and one to the downstream URA3 sequence so that only
plasmid, but not genomic yeast, DNA was ampliﬁed.
The PCR product was reintroduced into haploid yeast by
co-transformation with a partially overlapping gapped
plasmid, and the reporter gene plasmid was generated in
yeast by homologous recombination (32). The phenotype
of the genomic fragment was conﬁrmed in yeast after
mating to haploid yeast with the transcription factor.
In parallel, the PCR product was puriﬁed and sequenced.
This approach reduces manual processing of yeast clones,
speeds up screens and is adaptable to high-throughput
screening.
Characterization of thezebrafish genomic DNA
library using FoxI1
FoxI1 is a forkhead class transcription factor involved
in proper organization of the zebraﬁsh and mouse otic
vesicle and zebraﬁsh cranio-facial cartilage during early
embryonic development (33–36). Because FoxI1 can be
either an activator or a repressor in vivo (21), we fused
the open reading frame of FoxI1 to the Gal4 activating
domain (to ensure transcriptional activation) and screened
the zebraﬁsh library (to ensure transcriptional activation)
and screened the zebraﬁsh library (3 10
7 unique genomic
inserts, 4- to 6-fold coverage of the zebraﬁsh genome).
In parallel, we performed a control-mating assay for
haploid yeast with an empty plasmid. For this particular
screen, we cloned the FoxI1 open reading frame into the
pYOH-1 (modiﬁed from the Clontech plasmid pACT-1)
plasmid marked with ADE2. False-positives will not
need to maintain the FoxI1 plasmid to grow on SC-Ura
plates, so the colonies would take on a ‘sectored’ or all red
appearance. True-positives should remain completely
white.
Using the approach of Figure 1 and described for
p53, 2.5 10
7 diploid yeast were screened on plates lacking
uracil for 5 days at 308C. The negative control resulted
in 14 false-positive Ura
+ colonies per 1 10
6 diploid yeast
screened. In contrast, FoxI1 resulted in 132 Ura
+ colonies
per 1 10
6. A total of 710 white colonies were single
colony puriﬁed. We PCR-ampliﬁed the genomic inserts
directly from yeast and sequenced the fragments with
nested PCR primers. The fragments were simultaneously
re-tested in yeast as described before. All 710 fragments
were again Ura
+ and dependent on FoxI1 for growth.
Figure 2. Deﬁnition of p53 and FoxI1 consensus DNA-binding sites
based on genomic fragments isolated in yeast screens. (A) A ‘standard’
p53 PSSM (position-speciﬁc scoring matrix) model was obtained based
on alignment of 162 experimentally veriﬁed p53 DNA-binding sites.
A motif was predicted by applying the CONSENSUS program to
sequences of 94 library clones and was compared to the standard p53
DNA-binding site model. The logos of the standard motif and
predicted motif are shown. (B) The published human FoxI1-binding
site compared to the CONSENSUS predicted motifs of zebraﬁsh
FoxI1. Motif 1 is similar except for a noticeable diﬀerence at position 6
(T to A). Motif 2 matches the published consensus but with slightly
weaker preferences (core binding sequence is shifted from 4–8 to 5–9
in graph).
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forconsensus DNA-binding sites
p53. Of the 140 starting clones, 37 were duplicates and
3 had no insert. Of the remaining 100, 90 clones could
be fully sequenced using primers up- and downstream
of the genomic fragments, and 10 clones had an inte-
rior sequence gap. Sequences from the reference mouse
genome were retrieved to ﬁll the gap. The remaining six
clones were chimerical and could not be mapped precisely
because the sequencing gap included the region where the
two distinct genomic fragments join. The February 2006
mouse genome assembly and BLAT at http://genome.
ucsc.edu/were used to map the 94 complete clones. Thirty-
ﬁve clones could not be mapped because they contained
exclusively repetitive sequences. Of the remaining 59
clones, 33 were mapped to a single and 26 split clones to
more than one genomic locus (24 with 2, 1 with 3 and
1 with 4 fragments). Chimerical clones were a result of the
library construction because the genomic fragments had
compatible ends. In total, because of some chimerism,
59 clones mapped to 81 unique loci. Typically, chimeric
clones had a predicted binding site in only one of the two
(or more) genomic fragments in the clone. In summary,
 70% of library plasmids (94/140) were useful for the p53
DNA-binding site analysis and  40% could be uniquely
mapped to the genome.
The consensus p53 DNA-binding site is two half-
sites of RRRCWWGYYY separated by 0–13bp (2).
We built a new matrix from a larger data set of 162 p53
DNA-binding sites. According to the site predicted by
our 162 known p53-binding sites, the spacing of 0
between the p53 half-sites is much preferred over any
other spacing. This result was conﬁrmed in yeast assays
(26). A logo of this half-site model is shown in
Figure 2A.
We applied the CONSENSUS program (37) to 94 iso-
lated clones with complete sequence data. The best motif
is a 10bp approximate palindrome that matches our
standard p53 DNA-binding site model perfectly with
a P-value of 1.73 10
 6 (Figure 2A).
The p53 motif signal was very strong when analyzing
the complete set of 94 clones. To test whether we can
obtain an accurate motif for p53 with fewer sequences,
we generated random subsets of the 94 sequences ranging
from 5 to 50 and applied CONSENSUS to these data sets.
With 20 or more sequences, the top predictions matched
perfectly with our p53 DNA-binding site model at least
70% of the time. We then added two additional motif-
ﬁnding programs, Gibbs sampler (38) and Projection (39).
The combined sensitivity of these three programs was
100% on 10 random subsets of 20 sequences each indicat-
ing that just 20 genomic fragments per transcription factor
may be suﬃcient to characterize the majority of putative
transcription factors.
We mapped the likely p53 DNA-binding site in the
library sequences. Out of the 94 complete library clones,
81 contained at least one perfect p53 DNA-binding site.
Some clones contained as many as ﬁve predicted sites.
Eleven of the remaining clones contained a good match to
the p53 consensus DNA-binding site, but scored below
our very stringent cutoﬀ value. Two clones contained only
one good p53 half-site.
FoxI1. A total of 154 unique sequences were obtained
from the 710 total clones. One hundred and thirty-four of
the 154 unique sequences could be mapped to the zebraﬁsh
genome (zebraﬁsh build Zv6). Occasionally a sequence
mapped to more than one location with 100% identity,
these occurrences can often be explained by errors in the
current zebraﬁsh genomic build. In general, mapping was
less ‘robust’ because of high polymorphism rates in the
zebraﬁsh genome and the less ‘complete’ nature of the
assembly when compared to mouse. Approximately 50%
of the clones were chimeric consisting of two diﬀerent
fragments fused together (Supplementary Data).
Human FoxI1 (HFH-3, FREAC6, HNF-3, FKHL10)
binds to the motif TRTTTRKDD as determined by
SELEX enrichment (40). The CONSENSUS program
identiﬁed two common motifs in the isolated fragments.
The less frequent motif was identical to the published
binding site (Figure 2B), however, the more commonly
represented binding site, TSATTGGYY, while similar,
had some obvious diﬀerences (Figure 2B), particularly the
presence of an A in position 6 that is a T in the published
consensus. This could either reﬂect slight diﬀerences in
the preference of FoxI1 binding between the human and
zebraﬁsh forms, or diﬀerences in binding preference in the
context of histone packaging in vivo. Forkhead class
transcription factors have been shown to bind more stably
to DNA in the context of histones (41), this may change
the recognition site preferences when compared to in vitro
determinations. Thirteen fragments did not contain either
predicted motif. The discovery of another putative binding
site for FoxI1 as well as the conﬁrmation of the previously
published site reinforces the value of the technique. It is
of particular note that motif 1 contains the NF-Y core
sequence CCAAT, common in most eukaryotic promoters
(42). It is unclear what the presence of this sequence
signiﬁes, but NF-Y has been shown to be involved in
DNA compaction (43), similar to the role described for
FoxI1 (21), and like forkhead proteins, has a structure
that is similar to histones (44,45). Further study is needed
to determine the signiﬁcance of the CCAAT motif.
Identification of putative target genes
p53. Fifty-nine unique clones identiﬁed 81 fragments
with unique genomic locations because several clones
were chimeric. Of the 56 fragments with a good to excel-
lent p53 DNA-binding site, 10 mapped to introns. The
remaining fragments were found several thousand base
pairs up- or downstream of genes, similar to the ﬁndings
of ChIP studies for p53 (46,47) (Supplementary Data).
These 46 fragments would not have been sampled by
typical ‘promoter’ arrays. From the list of genes neigh-
boring the isolated fragments with p53 DNA-binding
sites, six genes (Sec61a2, Ass1, Aldh2, Kit1, Ela3b and
Rprm) are known to be up-regulated in a p53-dependent
fashion, but their p53 DNA-binding sites have not been
reported (48–51).
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mapped to 134 genomic loci. The remaining fragments
were unmappable (Supplementary Data). There were only
20 instances where the fragment mapped within 10kb
of the transcriptional start site. This is consistent with
a proposed second role for FoxI1 as a global chromatin
remodeling protein (21). There are not many genes known
to be directly regulated by FoxI1, but within the small set
of genes that have FoxI1 sites <10kb away, two genes,
Lhx3 and Cldna, have roles in ear development (52,53).
This makes them candidates for regulation by FoxI1 since
Foxl1 has a known role in ear development (34–36,54).
Invivo testing of zebrafish fragments
Recently developed techniques allow researchers to use
zebraﬁsh embryos as a rapid readout for testing in vivo
activity of putative cis-regulatory elements (55,56).
We selected 13 fragments and subcloned them into a
TOL2-based transposon vector containing Gateway
TM
compatible cloning sites upstream of a minimal promoter
and GFP (gift of A. McCallion). All 13 fragments showed
a signiﬁcant increase in GFP expression compared to
empty vector alone (Figure 3A). This demonstrated a
speciﬁc transcriptional response dependent on the inserted
genomic fragment since previous research has shown that
random genomic fragments do not consistently activate
GFP expression (55,56). Typically, expression of GFP
was similar to the known expression pattern of FoxI1
(Figure 3B). In order to demonstrate that transactivation
was dependent on FoxI1, we selected two fragments, z84
and z11, and tested them in the presence or absence of
morpholino oligonucleotides that inhibit FoxI1 expression
(OpenBiosystems). Fragment z11 showed no signiﬁcant
diﬀerences in the presence or absence of embryonic FoxI1.
However, fragment z84 showed a signiﬁcant increase
in GFP expression when FoxI1 protein was inhibited
(Figure 3C, P<0.001). We have previously demonstrated
that FoxI1 is capable of remodeling chromatin higher
order structure and only a few genes are activated or
inhibited by FoxI1 expression (21). In this study, we
further found that FoxI1 has an inhibitory role on GFP
expression in the context of certain genomic fragments.
It is likely that the FoxI1 binding is crucial to recruit other
transcription factor to the sites on those fragments that
are acting as positive and/or negative regulators.
In summary, the fragments isolated using the yeast
technique showed strong enrichment for cis-regulatory
elements (13/13 tested) and we have demonstrated in one
instance (of two tested) that FoxI1 is responsible for
transcriptional regulation from the fragment.
DISCUSSION
We present an approach in yeast that can rapidly identify
the target binding sequence of nearly any transcription
factor of interest, and simultaneously identify target sites
that are biologically active and relevant to the function of
that transcription factor. This redesigned and optimized
yeast approach combines three important elements:
(i) yeast mating (instead of transformation) for eﬃcient
screening of an entire genome in one pass; (ii) red/white
sectoring of the ADE2 gene for visual identiﬁcation of
false-positives and (iii) use of URA3 as the reporter gene
for expansion of libraries in 5-FOA to eliminate yeast with
Figure 3. In vivo testing of isolated FoxI1 fragments. (A) Relative
GFP activation compared to the empty TOL2 construct (pcfos).
(B) Comparison of GFP activation from several of the fragments
compared to the in situ expression pattern of FoxI1 (upper left). Some
genomicfragmentsmimicFoxI1expression,e.g.z100,whileothersappear
to have a diﬀerent pattern, (z84, z11). (C) Testing of fragment z84 in the
presence or absence of FoxI1 expression. z84 has clear activation over the
control empty vector, but when co-injected with FoxI1 targeting
morpholinos, the expression increases signiﬁcantly (P<0.0001).
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near zero. In two test cases, p53 and FoxI1, a yeast-based
screening approach proved to be a powerful and eﬃcient
way to study DNA-binding proteins. Recent studies using
our p53-binding site data as a starting point, have
identiﬁed endogenous retroviral (ERV) LTR’s carrying
functionally active p53-binding sites speciﬁc to the primate
lineage, indicating the potential utility of this approach
both to identify binding sites that are active in vivo, and
to make novel discoveries about cis-regulatory regions
in general (57). The genomic fragments can be directly
PCR-ampliﬁed from yeast for both sequencing and imme-
diate retesting in yeast using ‘gap repair’. The approach is
readily extended to hetero-dimeric or -multimeric trans-
cription factor complexes.
This technique provides a low-cost, potentially high-
throughput and rapid assessment of DNA-binding targets
for transcription factors that nicely complements the
current technologies, such as ChIP-Seq. We have shown
that DNA-binding sites can be predicted in as few as
20 isolated sequences and the identiﬁed fragments have
a very high likelihood of being biologically active.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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